DBV Technologies (DBVT) Revenue (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Revenue of $700000.0 for Q2 2026, down 53.33% year-on-year from $1.5 million in Q2 2025, and down 22.22% on a QoQ basis from $900000.0 in Q1 2026.
DBV Technologies (DBVT) Revenue (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Revenue for 7 consecutive years, with $700000.0 the latest figure, recorded in Q2 2026.
- Quarterly Revenue fell 53.33% year-over-year to $700000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.0 million (up 27.64% YoY) and the FY2025 annual result came in at $5.6 million, up 34.19% from the prior year.
- Revenue declined to $700000.0 in Q2 2026 per DBVT's latest filing, from $900000.0 in the prior quarter.
- Over the last five years, Revenue for DBVT reached as high as $8.9 million in Q4 2023 and fell as low as -$1.3 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.5 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue sank 144.47% — and 2023, when it jumped 780.6%.
- Year by year, Revenue stood at -$1.3 million in 2022, then soared by 780.6% to $8.9 million in 2023, then tumbled by 93.69% to $560000.0 in 2024, then increased by 15.18% to $645000.0 in 2025, then advanced by 8.53% to $700000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $700000.0, $900000.0, and $645000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.32 Mn |